These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3787198)

  • 1. A prospective randomized study on neodymium-YAG laser irradiation versus TUR in the treatment of urinary bladder cancer.
    Beisland HO; Seland P
    Scand J Urol Nephrol; 1986; 20(3):209-12. PubMed ID: 3787198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neodymium-YAG laser irradiation of stage T2 muscle-invasive bladder cancer. Long-term results.
    Beisland HO; Sander S
    Br J Urol; 1990 Jan; 65(1):24-6. PubMed ID: 2310928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A contribution to the special discussion on YAG laser irradiation of superficial bladder cancer.
    Beisland HO
    Acta Urol Belg; 1989; 57(3):693-5. PubMed ID: 2816584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of bladder cancer by Nd:YAG laser local irradiation and whole-bladder photodynamic therapy with hematoporphyrin derivative].
    Li CL; Xu BZ; Shong XY
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):458-60. PubMed ID: 7720506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neodymium:YAG laser therapy for infiltrating bladder cancer.
    McPhee MS; Arnfield MR; Tulip J; Lakey WH
    J Urol; 1988 Jul; 140(1):44-6. PubMed ID: 3379693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laser treatment for transitional cell cancer of the bladder].
    Silber N; Servadio C
    Harefuah; 1990 Jan; 118(1):8-10. PubMed ID: 2303201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection.
    Muraro GB; Grifoni R; Spazzafumo L
    Surg Technol Int; 2005; 14():222-6. PubMed ID: 16525976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neodymium:YAG laser irradiation of urinary bladder tumors. Follow-up study of 100 consecutively treated patients.
    Beisland HO; Sander S; Fossberg E
    Urology; 1985 Jun; 25(6):559-63. PubMed ID: 3839330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The neodymium:YAG laser in infiltrating bladder tumors].
    Spitzenpfeil E; Hofstetter A; Reis M; Muschter R
    Fortschr Med; 1989 Sep; 107(26):548-51. PubMed ID: 2807117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined laparoscopic and transurethral neodymium: yttrium-aluminum-garnet laser treatment of invasive bladder cancer.
    Gerber GS; Chodak GW; Rukstalis DB
    Urology; 1995 Feb; 45(2):230-3. PubMed ID: 7855971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy in the interdisciplinary approach to the treatment of bladder carcinoma].
    Dunst J
    Strahlenther Onkol; 1991 Oct; 167(10):563-80. PubMed ID: 1948642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral neodymium:YAG laser surgery for bladder tumors.
    Okada K; Asaoka H; Amagai T; Onoe Y; Kishimoto T
    Urology; 1982 Oct; 20(4):404-7. PubMed ID: 7147509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder perforation resulting from the use of the neodymium:YAG laser.
    Greskovich FJ; von Eschenbach AC
    Lasers Surg Med; 1991; 11(1):5-7. PubMed ID: 1997779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser treatment in urology: our experience with neodymium:YAG and carbon dioxide lasers.
    Sakkas G; Karagiannis A; Karayannis D; Dimopoulos K
    Int Urol Nephrol; 1995; 27(4):405-12. PubMed ID: 8586512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the neodymium:YAG laser effective therapy for invasive bladder cancer?
    Tarantino AE; Aretz HT; Libertino JA; Bihrle W; Dowd JB
    Urology; 1991 Dec; 38(6):514-8. PubMed ID: 1746077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
    Cervenakov I; Szoldova K; Mardiak J; Chovan D; Mala M; Slavov D
    Bratisl Lek Listy; 2000; 101(6):317-20. PubMed ID: 11039202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neodymium YAG laser in clinical urology. Current status and clinical experiences].
    Hofstetter AG; Keiditsch E; Schmiedt E; Frank F
    Fortschr Med; 1984 Sep; 102(36):885-90. PubMed ID: 6386635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Destruction of bladder neoplasms by means of transurethral neodym-YAG-laser coagulation].
    Staehler G; Schmiedt E; Hofstetter A
    Helv Chir Acta; 1978 Jul; 45(3):307-11. PubMed ID: 568126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.